SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 12:16 pm Purchase |
2023-12-31 | 13G | Sutro Biopharma, Inc. STRO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,778,188 9.500% |
213,089 (+3.83%) |
Filing |
| 2023-02-13 10:56 am Purchase |
2022-12-31 | 13G | Sutro Biopharma, Inc. STRO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,565,099 9.700% |
3,091,304 (+124.96%) |
Filing |
| 2022-02-11 4:49 pm Purchase |
2021-12-31 | 13G | Sutro Biopharma, Inc. STRO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,473,795 5.400% |
65,400 (+2.72%) |
Filing |
| 2021-12-10 4:31 pm Purchase |
2021-11-30 | 13G | Sutro Biopharma, Inc. STRO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,408,395 5.200% |
2,408,395 (New Position) |
Filing |